105 related articles for article (PubMed ID: 22310179)
1. Oroxylin A reverses CAM-DR of HepG2 cells by suppressing Integrinβ1 and its related pathway.
Zhu B; Zhao L; Zhu L; Wang H; Sha Y; Yao J; Li Z; You Q; Guo Q
Toxicol Appl Pharmacol; 2012 Mar; 259(3):387-94. PubMed ID: 22310179
[TBL] [Abstract][Full Text] [Related]
2. MAC-related mitochondrial pathway in oroxylin-A-induced apoptosis in human hepatocellular carcinoma HepG2 cells.
Liu W; Mu R; Nie FF; Yang Y; Wang J; Dai QS; Lu N; Qi Q; Rong JJ; Hu R; Wang XT; You QD; Guo QL
Cancer Lett; 2009 Nov; 284(2):198-207. PubMed ID: 19473757
[TBL] [Abstract][Full Text] [Related]
3. Involvement of p53 in oroxylin A-induced apoptosis in cancer cells.
Mu R; Qi Q; Gu H; Wang J; Yang Y; Rong J; Liu W; Lu N; You Q; Guo Q
Mol Carcinog; 2009 Dec; 48(12):1159-69. PubMed ID: 19626645
[TBL] [Abstract][Full Text] [Related]
4. Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway.
Lu Z; Lu N; Li C; Li F; Zhao K; Lin B; Guo Q
Toxicol Lett; 2012 Mar; 209(3):211-20. PubMed ID: 22245252
[TBL] [Abstract][Full Text] [Related]
5. Beclin 1-mediated autophagy in hepatocellular carcinoma cells: implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling.
Zou M; Lu N; Hu C; Liu W; Sun Y; Wang X; You Q; Gu C; Xi T; Guo Q
Cell Signal; 2012 Aug; 24(8):1722-32. PubMed ID: 22560876
[TBL] [Abstract][Full Text] [Related]
6. Oroxylin A reversed Fibronectin-induced glioma insensitivity to Temozolomide by suppressing IP
Ding Y; Zhou Y; Li Z; Zhang H; Yang Y; Qin H; Xu Q; Zhao L
Life Sci; 2020 Nov; 260():118411. PubMed ID: 32918978
[TBL] [Abstract][Full Text] [Related]
7. CXCL12/CXCR4 axis confers adriamycin resistance to human chronic myelogenous leukemia and oroxylin A improves the sensitivity of K562/ADM cells.
Wang Y; Miao H; Li W; Yao J; Sun Y; Li Z; Zhao L; Guo Q
Biochem Pharmacol; 2014 Aug; 90(3):212-25. PubMed ID: 24858801
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 7-O-modified oroxylin A derivatives.
Fu W; Wang J; Yu L; Zhao L; Lu N; You Q; Guo Q; Li Z
Bioorg Med Chem Lett; 2012 Jan; 22(2):1118-21. PubMed ID: 22196122
[TBL] [Abstract][Full Text] [Related]
9. Oroxylin A suppresses invasion through down-regulating the expression of matrix metalloproteinase-2/9 in MDA-MB-435 human breast cancer cells.
Sun Y; Lu N; Ling Y; Gao Y; Chen Y; Wang L; Hu R; Qi Q; Liu W; Yang Y; You Q; Guo Q
Eur J Pharmacol; 2009 Jan; 603(1-3):22-8. PubMed ID: 19100732
[TBL] [Abstract][Full Text] [Related]
10. Oroxylin A induced apoptosis of human hepatocellular carcinoma cell line HepG2 was involved in its antitumor activity.
Hu Y; Yang Y; You QD; Liu W; Gu HY; Zhao L; Zhang K; Wang W; Wang XT; Guo QL
Biochem Biophys Res Commun; 2006 Dec; 351(2):521-7. PubMed ID: 17069758
[TBL] [Abstract][Full Text] [Related]
11. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
12. Oroxylin A reverses multi-drug resistance of human hepatoma BEL7402/5-FU cells via downregulation of P-glycoprotein expression by inhibiting NF-κB signaling pathway.
Yang HY; Zhao L; Yang Z; Zhao Q; Qiang L; Ha J; Li ZY; You QD; Guo QL
Mol Carcinog; 2012 Feb; 51(2):185-95. PubMed ID: 21557331
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis induction of oroxylin A in human cervical cancer HeLa cell line in vitro and in vivo.
Li HN; Nie FF; Liu W; Dai QS; Lu N; Qi Q; Li ZY; You QD; Guo QL
Toxicology; 2009 Mar; 257(1-2):80-5. PubMed ID: 19135124
[TBL] [Abstract][Full Text] [Related]
14. Engagement of integrinβ1 induces resistance of bladder cancer cells to mitomycin-C.
Zhang CJ; Shen ZJ; Pan CW; Zhong S; Li T; Zhang MG
Urology; 2012 Mar; 79(3):638-43. PubMed ID: 22386417
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis.
Tang C; Lu YH; Xie JH; Wang F; Zou JN; Yang JS; Xing YY; Xi T
Anticancer Drugs; 2009 Apr; 20(4):249-58. PubMed ID: 19174695
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis in human hepatocarcinoma SMMC-7721 cells in vitro by flavonoids from Astragalus complanatus.
Hu YW; Liu CY; Du CM; Zhang J; Wu WQ; Gu ZL
J Ethnopharmacol; 2009 Jun; 123(2):293-301. PubMed ID: 19429375
[TBL] [Abstract][Full Text] [Related]
17. Comparative two-dimensional HepG2 and L02/ cell membrane chromatography/ C18/ time-of-flight mass spectrometry for screening selective anti-hepatoma components from Scutellariae Radix.
Gu Y; Chen X; Wang R; Wang S; Wang X; Zheng L; Zhang B; Chai Y; Zhu Z; Yuan Y
J Pharm Biomed Anal; 2019 Feb; 164():550-556. PubMed ID: 30458388
[TBL] [Abstract][Full Text] [Related]
18. GL-V9, a newly synthetic flavonoid derivative, induces mitochondrial-mediated apoptosis and G2/M cell cycle arrest in human hepatocellular carcinoma HepG2 cells.
Li L; Lu N; Dai Q; Wei L; Zhao Q; Li Z; He Q; Dai Y; Guo Q
Eur J Pharmacol; 2011 Nov; 670(1):13-21. PubMed ID: 21944925
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of cytotoxic and pro-apoptotic effects of 2-aminophenoxazine-3-one on the rat hepatocellular carcinoma cell line dRLh-84, the human hepatocellular carcinoma cell line HepG2, and the rat normal hepatocellular cell line RLN-10 in combination with 2-deoxy-D-glucose.
Takemura A; Che XF; Tabuchi T; Moriya S; Miyazawa K; Tomoda A
Oncol Rep; 2012 Feb; 27(2):347-55. PubMed ID: 22076586
[TBL] [Abstract][Full Text] [Related]
20. On-line comprehensive two-dimensional HepG2 cell membrane chromatographic analysis system for charactering anti-hepatoma components from rat serum after oral administration of Radix scutellariae: A strategy for rapid screening active compounds in vivo.
Jia D; Chen X; Cao Y; Wu X; Ding X; Zhang H; Zhang C; Chai Y; Zhu Z
J Pharm Biomed Anal; 2016 Jan; 118():27-33. PubMed ID: 26512996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
